NO20040254L - Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav - Google Patents

Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav

Info

Publication number
NO20040254L
NO20040254L NO20040254A NO20040254A NO20040254L NO 20040254 L NO20040254 L NO 20040254L NO 20040254 A NO20040254 A NO 20040254A NO 20040254 A NO20040254 A NO 20040254A NO 20040254 L NO20040254 L NO 20040254L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
containing terbinafine
terbinafine
pharmaceutical
Prior art date
Application number
NO20040254A
Other languages
English (en)
Other versions
NO332268B1 (no
Inventor
Rainer Alles
Oskar Kalb
Stefan Hirsch
Dieter Becker
Jean-Daniel Bonny
Ernst Ulrich Kolle
Friedrich Karl Mayer
Anton Stuetz
Anthony Williams
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27256227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040254(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0117760A external-priority patent/GB0117760D0/en
Priority claimed from GB0128993A external-priority patent/GB0128993D0/en
Priority claimed from GB0212209A external-priority patent/GB0212209D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20040254L publication Critical patent/NO20040254L/no
Publication of NO332268B1 publication Critical patent/NO332268B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20040254A 2001-07-20 2004-01-19 Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav NO332268B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0117760A GB0117760D0 (en) 2001-07-20 2001-07-20 Organic compounds
GB0128993A GB0128993D0 (en) 2001-12-04 2001-12-04 Organic compounds
GB0212209A GB0212209D0 (en) 2002-05-27 2002-05-27 Organic compounds
PCT/EP2002/008095 WO2003022267A1 (en) 2001-07-20 2002-07-19 Pharmaceutical compositions containing terbinafin and use thereof

Publications (2)

Publication Number Publication Date
NO20040254L true NO20040254L (no) 2004-03-22
NO332268B1 NO332268B1 (no) 2012-08-13

Family

ID=27256227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040254A NO332268B1 (no) 2001-07-20 2004-01-19 Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav

Country Status (28)

Country Link
US (2) US20040198838A1 (no)
EP (1) EP1411921B2 (no)
JP (3) JP2005503399A (no)
KR (2) KR100651110B1 (no)
CN (1) CN100358518C (no)
AR (1) AR034813A1 (no)
AT (1) ATE381329T1 (no)
AU (1) AU2002321249B2 (no)
BR (1) BR0211198A (no)
CA (1) CA2453263C (no)
CY (1) CY1107861T1 (no)
DE (1) DE60224194T3 (no)
DK (1) DK1411921T4 (no)
ES (1) ES2295381T5 (no)
HK (1) HK1067299A1 (no)
HU (1) HUP0401200A3 (no)
IL (2) IL159591A0 (no)
MX (1) MXPA04000627A (no)
MY (1) MY136136A (no)
NO (1) NO332268B1 (no)
NZ (1) NZ530648A (no)
PE (1) PE20030287A1 (no)
PL (1) PL365416A1 (no)
PT (1) PT1411921E (no)
RU (1) RU2298402C2 (no)
SI (1) SI1411921T2 (no)
TW (1) TWI302460B (no)
WO (1) WO2003022267A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
US20050209339A1 (en) * 2002-07-02 2005-09-22 Ercem Atillasoy Methods for the treatment of sinusitis
JP2005060310A (ja) * 2003-08-13 2005-03-10 Towa Yakuhin Kk 不快な味をマスキングする経口投与用製剤
JP2005187339A (ja) * 2003-12-24 2005-07-14 Iwaki Seiyaku Co Ltd 耐光性塩酸テルビナフィンフィルムコート錠
JP4999297B2 (ja) * 2005-08-10 2012-08-15 高田製薬株式会社 高含量塩酸テルビナフィン小型錠剤
WO2007110753A2 (en) * 2006-03-28 2007-10-04 Wockhardt Ltd Extended release dosage forms of metoprolol
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
NZ703464A (en) 2006-04-26 2016-05-27 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
BRPI0712255A2 (pt) * 2006-06-07 2012-01-17 Novartis Ag processo para multiparticulados usando um compactador cilìndrico
TWI468191B (zh) * 2009-01-28 2015-01-11 Novartis Ag 有機化合物之調配物
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
CN102198111A (zh) * 2011-06-17 2011-09-28 哈尔滨乐泰药业有限公司 一种抗真菌药物片剂的制备方法
WO2013043143A1 (ru) * 2011-09-21 2013-03-28 Slyusar Viktor Timopheevich Способ снижения лишнего веса
WO2013134348A1 (en) * 2012-03-07 2013-09-12 Santarus, Inc. Controlled-release solid dosage forms of mesalamine
DK3429559T3 (da) 2016-03-15 2022-07-11 Acer Therapeutics Inc Velsmagende sammensætninger indeholdende natriumphenylbutyrat og anvendelser deraf
WO2018069388A1 (en) 2016-10-11 2018-04-19 Khalifa University of Science and Technology Coated chloride salt particles and methods of making and using the same
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
CN109833301A (zh) * 2017-11-29 2019-06-04 天津市保灵动物保健品有限公司 一种犬猫用盐酸特比萘芬风味片及其制备工艺
CN109925296B (zh) * 2017-12-19 2021-09-07 四川济生堂药业有限公司 一种中药微丸的包衣方法
CN112156078A (zh) * 2020-11-11 2021-01-01 乐泰药业有限公司 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
AU2022253899A1 (en) 2021-04-07 2023-10-26 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) † 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
WO1995016465A1 (en) * 1993-12-14 1995-06-22 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
CA2184535C (en) * 1996-08-30 2000-04-18 H. Craig Willis Apparatus and method for separation of solids from liquid
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
TR199901564T2 (xx) * 1997-01-06 1999-09-21 Pfizer Inc. H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu.
US6342250B1 (en) * 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
FR2771291B1 (fr) † 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
DE19842753A1 (de) † 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
AU753476B2 (en) * 1998-11-25 2002-10-17 Cima Labs, Inc. Taste masking rapid release coating system
ES2197600T3 (es) † 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
US6248363B1 (en) † 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CN1116033C (zh) * 1999-07-08 2003-07-30 齐鲁制药厂 一种治疗阴道炎的泡腾片剂及其制法
EP1202716A1 (en) * 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
CA2400784C (en) † 2000-02-24 2009-05-19 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
US20040198828A1 (en) * 2003-01-17 2004-10-07 Abelson Mark B. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
KR100699958B1 (ko) 2007-03-28
MY136136A (en) 2008-08-29
PT1411921E (pt) 2008-03-12
NO332268B1 (no) 2012-08-13
HUP0401200A2 (hu) 2004-10-28
EP1411921B2 (en) 2010-08-18
TWI302460B (en) 2008-11-01
KR20040028935A (ko) 2004-04-03
DK1411921T4 (da) 2010-11-08
US20080286356A1 (en) 2008-11-20
HK1067299A1 (en) 2005-04-08
ES2295381T5 (es) 2011-01-31
DE60224194D1 (de) 2008-01-31
US20040198838A1 (en) 2004-10-07
EP1411921A1 (en) 2004-04-28
NZ530648A (en) 2007-04-27
JP2012136523A (ja) 2012-07-19
SI1411921T2 (sl) 2010-12-31
CA2453263C (en) 2010-12-07
BR0211198A (pt) 2004-08-10
HUP0401200A3 (en) 2008-03-28
MXPA04000627A (es) 2004-04-20
CA2453263A1 (en) 2003-03-20
JP2008280351A (ja) 2008-11-20
PE20030287A1 (es) 2003-05-06
DE60224194T2 (de) 2008-12-24
WO2003022267A1 (en) 2003-03-20
DE60224194T3 (de) 2011-03-17
SI1411921T1 (sl) 2008-06-30
IL159591A (en) 2012-06-28
RU2298402C2 (ru) 2007-05-10
DK1411921T3 (da) 2008-04-21
CN1527706A (zh) 2004-09-08
KR20060076331A (ko) 2006-07-04
CY1107861T1 (el) 2013-06-19
PL365416A1 (en) 2005-01-10
ATE381329T1 (de) 2008-01-15
JP2005503399A (ja) 2005-02-03
ES2295381T3 (es) 2008-04-16
CN100358518C (zh) 2008-01-02
RU2004105263A (ru) 2005-04-20
IL159591A0 (en) 2004-06-01
EP1411921B1 (en) 2007-12-19
AU2002321249B2 (en) 2005-10-27
KR100651110B1 (ko) 2006-12-21
AR034813A1 (es) 2004-03-17

Similar Documents

Publication Publication Date Title
NO20040254L (no) Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav
NO20033565D0 (no) Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
NO20033566D0 (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
NO20050830L (no) Acylerte heteroarylkondenserte sykloalkenylaminer og deres anvendelse som farmasoytiske midler
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
NO20033384L (no) Farmasoytisk formulering
NO20043904L (no) Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
NO20033785D0 (no) Farmasöytisk formulering
FI20011478A0 (fi) Farmaseuttinen koostumus
DK1484970T3 (da) Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
NO20035627D0 (no) Farmasöytisk formulering
EE200300589A (et) Ravimkoostised
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
FI20022128A (fi) Farmaseuttinen koostumus
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
NO20040214L (no) Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
DK1429753T3 (da) Farmaceutisk sammensætning omfattende gamma-butyrobetain
DK1453783T3 (da) Substituerede arylcycloalkaner og deres anvendelse som anticancermidler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees